[
  {
    "question": "The most significant risk factor for Invasive Pulmonary Aspergillosis in hematological malignancies is?",
    "options": {
      "A": "Neutropenia",
      "B": "Lymphopenia",
      "C": "Thrombocytopenia",
      "D": "Anemia"
    },
    "correctAnswer": "A",
    "topic": "ipa",
    "deepDiveExplanation": "Prolonged and profound neutropenia (<500 neutrophils/µL for >10 days) is the most critical risk factor for Invasive Pulmonary Aspergillosis (IPA), particularly in patients with hematological malignancies undergoing chemotherapy or hematopoietic stem cell transplantation. Neutrophils are crucial for clearing inhaled conidia and hyphae.",
    "highYieldPearl": "Neutropenia is the bedrock risk factor for IPA; without it, the risk plummets significantly.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "While other cytopenias might be present, neutropenia directly impairs the primary host defense against Aspergillus, making it the most significant risk factor.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_upooolad"
  },
  {
    "question": "Which imaging sign is characteristic of early Invasive Pulmonary Aspergillosis in neutropenic patients?",
    "options": {
      "A": "Tree-in-bud sign",
      "B": "Halo sign",
      "C": "Air bronchogram",
      "D": "Ground-glass opacities"
    },
    "correctAnswer": "B",
    "topic": "ipa",
    "deepDiveExplanation": "The halo sign, characterized by a nodule or mass surrounded by ground-glass attenuation, represents hemorrhage around the necrotic fungal lesion. It is highly suggestive of angioinvasive fungal infection, including IPA, in neutropenic patients and typically appears early in the disease course.",
    "highYieldPearl": "Halo sign = hemorrhage around fungal nodule = early IPA in neutropenia.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Tree-in-bud sign suggests bronchiolar inflammation/infection. Air bronchogram is common in consolidation. Ground-glass opacities are non-specific but can be part of the halo sign.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_sxocxdlc"
  },
  {
    "question": "The 'air-crescent sign' on CT chest is typically seen during which phase of Invasive Pulmonary Aspergillosis recovery?",
    "options": {
      "A": "Early infection",
      "B": "Neutropenia phase",
      "C": "Neutrophil recovery",
      "D": "Chronic phase"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "The air-crescent sign, where a crescentic lucency separates a necrotic fungal lesion from the adjacent lung parenchyma, typically appears during the recovery phase, particularly as neutrophil counts rebound. It indicates separation of the necrotic core from the viable lung due to host inflammatory response.",
    "highYieldPearl": "Air-crescent sign signifies neutrophil recovery and tissue demarcation in IPA.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "The halo sign is early (neutropenic phase), while the air-crescent sign is a later, more favorable prognostic sign associated with immune reconstitution.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_3pjs0uqv"
  },
  {
    "question": "Which fungal polysaccharide is detected in serum or BAL fluid for diagnosing Invasive Pulmonary Aspergillosis?",
    "options": {
      "A": "(1,3)-β-D-glucan",
      "B": "Galactomannan",
      "C": "Chitin",
      "D": "Mannan"
    },
    "correctAnswer": "B",
    "topic": "ipa",
    "deepDiveExplanation": "Galactomannan is a cell wall polysaccharide of Aspergillus species that is released during active fungal growth and can be detected in serum, bronchoalveolar lavage (BAL) fluid, and cerebrospinal fluid. It is a key biomarker for diagnosing IPA, especially in high-risk patients.",
    "highYieldPearl": "Galactomannan is specific for *Aspergillus* and *Penicillium* (less commonly), differentiating it from general fungal markers.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "(1,3)-β-D-glucan is a general fungal biomarker, less specific than galactomannan for Aspergillus. Chitin is a general fungal cell wall component but not typically used as a diagnostic biomarker. Mannan is a component of *Candida* cell walls.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_jdcaear6"
  },
  {
    "question": "The (1,3)-β-D-glucan assay for fungal infection diagnosis has limitations due to cross-reactivity with?",
    "options": {
      "A": "*Candida* species",
      "B": "*Pneumocystis jirovecii*",
      "C": "Dialysis membranes",
      "D": "*Aspergillus* species"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "The (1,3)-β-D-glucan assay detects a common component of many fungal cell walls, making it useful for broad fungal detection. However, false positives can occur with certain medical products, including cellulose membranes used in hemodialysis, surgical gauze, and some intravenous immunoglobulins.",
    "highYieldPearl": "Beta-D-glucan is a general fungal marker, but consider non-fungal causes for elevation, especially in critically ill patients.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Options A, B, and D are all fungi that would typically *cause* a positive (1,3)-β-D-glucan, not cross-react in a way that limits its utility for general fungal detection. The question asks for limitations due to cross-reactivity with non-fungal sources.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_1d5sdoy4"
  },
  {
    "question": "What is the recommended first-line antifungal agent for the treatment of Invasive Pulmonary Aspergillosis?",
    "options": {
      "A": "Fluconazole",
      "B": "Amphotericin B deoxycholate",
      "C": "Voriconazole",
      "D": "Caspofungin"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "Voriconazole is the current first-line therapy for Invasive Pulmonary Aspergillosis, based on superior efficacy and improved survival compared to amphotericin B deoxycholate in randomized controlled trials. Isavuconazole is an alternative primary therapy.",
    "highYieldPearl": "Voriconazole is the gold standard for IPA treatment.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Fluconazole has no activity against *Aspergillus*. Amphotericin B was historically used but has more toxicity and less efficacy than voriconazole. Caspofungin (an echinocandin) is used as salvage therapy or in combination, not typically first-line monotherapy.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_455h5584"
  },
  {
    "question": "Azole antifungals primarily exert their action by inhibiting which fungal enzyme?",
    "options": {
      "A": "(1,3)-β-D-glucan synthase",
      "B": "DNA topoisomerase",
      "C": "Cytochrome P450 14α-demethylase",
      "D": "Chitin synthase"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "Azole antifungals inhibit the fungal cytochrome P450 14α-demethylase enzyme, which is crucial for the synthesis of ergosterol, a vital component of the fungal cell membrane. This inhibition leads to cell membrane dysfunction and ultimately fungal cell death.",
    "highYieldPearl": "Azoles target ergosterol synthesis via CYP450 14α-demethylase.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "(1,3)-β-D-glucan synthase is targeted by echinocandins. DNA topoisomerase is a target for some antibacterial/anticancer drugs. Chitin synthase is involved in cell wall synthesis, but not a primary azole target.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_padtnxfi"
  },
  {
    "question": "The definitive diagnosis of Invasive Pulmonary Aspergillosis relies on demonstration of hyphae with which characteristic?",
    "options": {
      "A": "Broadly septate, parallel walls",
      "B": "Non-septate, irregular branching",
      "C": "Narrowly septate, acute angle branching",
      "D": "Yeast forms with pseudohyphae"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "Histopathological examination showing septate hyphae with characteristic acute angle (typically 45°) dichotomous branching within tissue is the gold standard for definitive diagnosis of IPA. This distinguishes *Aspergillus* from other fungi like *Mucorales* (non-septate, irregular branching) or *Candida* (yeast and pseudohyphae).",
    "highYieldPearl": "Acute angle branching, septate hyphae in tissue = definitive Aspergillus.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Option B describes *Mucorales*. Option D describes *Candida*. Option A is vague and less specific than the classic description for Aspergillus.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_khdbhf31"
  },
  {
    "question": "Therapeutic drug monitoring is routinely recommended for which antifungal used in Invasive Pulmonary Aspergillosis?",
    "options": {
      "A": "Amphotericin B",
      "B": "Caspofungin",
      "C": "Voriconazole",
      "D": "Micafungin"
    },
    "correctAnswer": "C",
    "topic": "ipa",
    "deepDiveExplanation": "Voriconazole exhibits non-linear pharmacokinetics, significant inter-patient variability, and potential for drug-drug interactions, leading to highly variable plasma concentrations. Therapeutic drug monitoring (TDM) is recommended to ensure adequate therapeutic levels while minimizing toxicity, particularly neurotoxicity and hepatotoxicity.",
    "highYieldPearl": "Voriconazole TDM is crucial due to variable pharmacokinetics and narrow therapeutic window.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Amphotericin B and echinocandins (caspofungin, micafungin) have more predictable pharmacokinetics and broader therapeutic windows, so TDM is not routinely recommended for them.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_n4jcujvq"
  },
  {
    "question": "The most common mechanism of azole resistance in *Aspergillus fumigatus* is mutations in which gene?",
    "options": {
      "A": "*ERG11*",
      "B": "*CYP51A*",
      "C": "*FKS1*",
      "D": "*MDR1*"
    },
    "correctAnswer": "B",
    "topic": "ipa",
    "deepDiveExplanation": "The most prevalent mechanism of azole resistance in *Aspergillus fumigatus* is target site modification, specifically mutations in the *CYP51A* gene. This gene encodes the 14α-demethylase enzyme, which is the direct target of azole antifungals. Common mutations include TR34/L98H and TR46/Y121F/T289A.",
    "highYieldPearl": "Azole resistance in *Aspergillus* often linked to *CYP51A* mutations, especially TR34/L98H.",
    "examStyle": "NEET-SS",
    "difficulty": "Hard",
    "trapAnalysis": "*ERG11* is the gene encoding 14α-demethylase in *Candida* species. *FKS1* mutations are associated with echinocandin resistance. *MDR1* relates to efflux pumps, which can contribute to resistance but *CYP51A* mutations are the primary mechanism for azole resistance in *Aspergillus*.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ipa|Invasive Pulmonary Aspergillosis|10_3uuqei63"
  }
]